{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:52:15Z","timestamp":1768420335164,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejphar.2023.175747","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T20:40:09Z","timestamp":1683060009000},"page":"175747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0\/G1 phase arrest"],"prefix":"10.1016","volume":"951","author":[{"given":"Jiayan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Zhanghuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinkui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-5886","authenticated-orcid":false,"given":"Dawei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175747_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1541-7786.MCR-20-0867","article-title":"AP-2alpha regulates S-phase and is a marker for sensitivity to PI3K inhibitor buparlisib in colon cancer","volume":"19","author":"Beck","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175747_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/ml200156t","article-title":"Identification of NVP-BKM120 as a potent, selective, orally bioavailable class I PI3 kinase inhibitor for treating cancer","volume":"2","author":"Burger","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2023.175747_bib3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.175747_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12935-020-01427-0","article-title":"A high-throughput drug combination screen identifies an anti-glioma synergism between TH588 and PI3K inhibitors","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2023.175747_bib5","first-page":"e551","article-title":"Clinical and prognostic characteristics of 53 cases of extracranial malignant rhabdoid tumor in children","volume":"24","author":"Cheng","year":"2019","journal-title":"A Single-Instit. Exp. from 2007 to 2017. Oncol."},{"key":"10.1016\/j.ejphar.2023.175747_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.668247","article-title":"PI3K promotes basal cell carcinoma growth through kinase-induced p21 degradation","volume":"11","author":"Chow","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175747_bib7","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/cncr.26684","article-title":"Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study","volume":"118","author":"Dufour","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2023.175747_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2021.10.025","article-title":"Extracranial rhabdoid tumours: results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations","volume":"161","author":"Enault","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175747_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cncr.30405","article-title":"Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database","volume":"123","author":"Fischer-Valuck","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2023.175747_bib10","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1158\/1078-0432.CCR-14-3026","article-title":"Systematic screening identifies dual PI3K and mTOR inhibition as a conserved therapeutic vulnerability in osteosarcoma","volume":"21","author":"Gupte","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175747_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2023.175747_bib12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41416-020-01074-2","article-title":"Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck","volume":"123","author":"Kim","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175747_bib13","series-title":"Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of the Korean Pediatric Hematology and Oncology Group (KPHOG) Data","author":"Koh","year":"2022"},{"key":"10.1016\/j.ejphar.2023.175747_bib14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s10388-022-00928-3","article-title":"Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303)","volume":"19","author":"Kojima","year":"2022","journal-title":"Esophagus"},{"key":"10.1016\/j.ejphar.2023.175747_bib15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.175747_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-20-1008","article-title":"A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer","volume":"27","author":"Lu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175747_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/CAD.0b013e3283375d5c","article-title":"Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines","volume":"21","author":"Lunenburger","year":"2010","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejphar.2023.175747_bib18","article-title":"The inhibitory response to PI3K\/AKT pathway inhibitors MK-2206 and buparlisib is related to genetic differences in pancreatic ductal adenocarcinoma cell lines","volume":"23","author":"Ma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175747_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1535-7163.MCT-11-0474","article-title":"Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor","volume":"11","author":"Maira","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2023.175747_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932337","article-title":"Molecular heterogeneity in pediatric malignant rhabdoid tumors in patients with multi-organ involvement","volume":"12","author":"Miller","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175747_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/annonc\/mdw552","article-title":"Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism","volume":"28","author":"Morel","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2023.175747_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14728222.2018.1451839","article-title":"Emerging therapeutic targets for the treatment of malignant rhabdoid tumors","volume":"22","author":"Nemes","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2023.175747_bib23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40618-021-01735-w","article-title":"PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells","volume":"45","author":"Oliveira","year":"2022","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ejphar.2023.175747_bib24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/aps.2012.72","article-title":"PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes","volume":"33","author":"Pal","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175747_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1101\/gad.14.9.1027","article-title":"Protein-protein interactions define specificity in signal transduction","volume":"14","author":"Pawson","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2023.175747_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12890-021-01571-x","article-title":"Dual targeting of MEK and PI3K effectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with different genetic backgrounds","volume":"21","author":"Qu","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ejphar.2023.175747_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/14728222.2022.2040017","article-title":"Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets","volume":"26","author":"Rechberger","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2023.175747_bib28","first-page":"7","volume":"vol. 72","author":"Siegel","year":"2022"},{"key":"10.1016\/j.ejphar.2023.175747_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tox.2009.09.014","article-title":"Application of connectivity mapping in predictive toxicology based on gene-expression similarity","volume":"268","author":"Smalley","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2023.175747_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106403","article-title":"Targeting Akt\/PKB in pediatric tumors: a review from preclinical to clinical trials","volume":"183","author":"Toson","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.175747_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pbc.22922","article-title":"Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group","volume":"56","author":"van den Heuvel-Eibrink","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejphar.2023.175747_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jid.2020.05.110","article-title":"Cutaneous T-cell lymphoma PDX drug screening platform identifies cooperation between inhibitions of PI3Kalpha\/delta and HDAC","volume":"141","author":"Wu","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2023.175747_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41419-021-03805-6","article-title":"BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:17:20Z","timestamp":1757978240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"alternative-id":["S0014299923002583"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175747","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0\/G1 phase arrest","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175747"}}